GNAO1 PerlQuest
PerlQuest Partners
“This is an exciting time for patients and precision medicine. A few years ago, genomics finally made it possible to bring diagnoses to many patients. Now, precision medicine — fully embodied in this collaboration — offers the hope of finding treatments.”
Matt Might
Advisor to the Undiagnosed Diseases Network Coordinating Center, faculty member at the Department of Biomedical Informatics at Harvard Medical School, and Director of the Hugh Kaul Precision Medicine Institute at the University of Alabama at Birmingham
Advisor to the Undiagnosed Diseases Network Coordinating Center, faculty member at the Department of Biomedical Informatics at Harvard Medical School, and Director of the Hugh Kaul Precision Medicine Institute at the University of Alabama at Birmingham
Community Partners
“The Bow Foundation is excited to continue increasing GNAO1 awareness as a Perlara community partner on their GNAO1 PerlQuest. Perlara’s work will help put children with a GNAO1 related neurodevelopmental disorder further on the radar of researchers and pharmaceutical companies. We look forward to working together towards a better tomorrow for children with a GNAO1 disorder.”
—Alice Fox & Emily Bell
Co-Founders and Co-Chairs of the Bow Foundation
Co-Founders and Co-Chairs of the Bow Foundation